title: Selective cyclooxygenase-2 inhibition produces heterogeneous erythema response to ultraviolet irradiation.
authors.forename: Cristina
authors.initials: C
authors.lastname: Rodriguez-Burford
authors.forename: John H
authors.initials: JH
authors.lastname: Tu
authors.forename: Marygail
authors.initials: M
authors.lastname: Mercurio
authors.forename: Delicia
authors.initials: D
authors.lastname: Carey
authors.forename: Rujing
authors.initials: R
authors.lastname: Han
authors.forename: Gary
authors.initials: G
authors.lastname: Gordon
authors.forename: Santosh
authors.initials: S
authors.lastname: Niwas
authors.forename: Walter
authors.initials: W
authors.lastname: Bell
authors.forename: Craig A
authors.initials: CA
authors.lastname: Elmets
authors.forename: William
authors.initials: W
authors.lastname: Grizzle
authors.forename: Alice P
authors.initials: AP
authors.lastname: Pentland
mesh_terms: D000068579:Celecoxib; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004890:Erythema / Q000532:radiotherapy*; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D016861:Cyclooxygenase Inhibitors; D008565:Membrane Proteins; D018809:Proliferating Cell Nuclear Antigen; D011720:Pyrazoles; D013449:Sulfonamides; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D000068579:Celecoxib